From July 1, 2022 to September 30, 2022, the company has repurchased 30,000 shares, representing 0.09% for KRW 461 million. With this, the company has completed the repurchase of 1,638,038 shares, representing 4.63% for KRW 27,613.64 million under the buyback announced on March 24, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,180 KRW | -3.36% | +4.66% | -19.96% |
2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
1st Jan change | Capi. | |
---|---|---|
-19.96% | 186M | |
-5.27% | 12.32B | |
-3.86% | 8.07B | |
+33.66% | 5.52B | |
-7.35% | 4.21B | |
-55.63% | 2.99B | |
+13.62% | 2.73B | |
-3.65% | 2.43B | |
+30.67% | 2.29B | |
-4.31% | 1.89B |
- Stock Market
- Equities
- A950130 Stock
- News Access Bio, Inc.
- Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.